Crossmark

No difference in return to play rates between different elite sports after primary autograft ACL reconstruction

Crossref DOI link: https://doi.org/10.1007/s00167-023-07654-y

Published Online: 2023-11-10

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jones, Mary https://orcid.org/0000-0002-9293-8922
Hugo Pinheiro, Vitor

Balendra, Ganesh

Borque, Kyle

Williams, Andy
Funding

Funding for this research was provided by:

Smith and Nephew
License Information

Version of Record valid from 2023-11-10

Text and Data Mining valid from 2023-11-10

Version of Record valid from 2023-11-10
More Information

Article History

Received: 4 August 2023

Accepted: 24 October 2023

First Online: 10 November 2023

Declarations

:

: AW receives an educational grant from Smith and Nephew to part fund a knee fellowship and has also received funding for research and payments for speaking. He also owns stock in a DoccComms, a digital start-up company developing an app for secure medical communications and Innovate, an orthopaedic company making interference screws.

: REC approval was not required but approval to undertake the study was given by the institution involved in line with UK Health Research Authority guidance.

: As a retrospective evaluation of treatment already given and as no identifiable information is included, informed consent was not sought from the subjects.